Induction of cancer cell-specific death via MMP2 promoterdependent Bax expression

Eunjeong Seo, Sewoon Kim, Eek hoon Jho

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Controlled gene expression in specific cells is a valuable tool for gene therapy. We attempted to determine whether the lentivirus-mediated Tet-On inducible system could be applied to cancer gene therapy. In order to select the genes that induce cancer cell death, we compared the ability of the known pro-apoptotreic genes, Bax and tBid, and a cell cycle inhibitor, p21cip1/waf1, and determined that Bax was the most effective. For the cancer cell-specific expression of rtTA2S-M2, we tested the matrix metalloproteinase-2 (MMP-2) promoter and determined that it is highly expressed in cancer cell lines, including SNU475 cells. The co-transduction of two lentiviruses that contain sequences for TRE-Bax and rtTA2S-M2, the expression of which is controlled by the MMP-2 promoter, resulted in the specific cell death of SNU475, whereas other cells with low MMP-2 expression did not evidence significant cell death. Our data indicate that the lentivirus-mediated Tet-On system using the cancer-specific promoter is applicable for cancer gene therapy.

Original languageEnglish
Pages (from-to)217-222
Number of pages6
JournalBMB Reports
Issue number4
StatePublished - Apr 2009


  • Cancer gene therapy
  • Lentivirus
  • MMP-2 promoter
  • Proapoptotic gene
  • Tet-on inducible system


Dive into the research topics of 'Induction of cancer cell-specific death via MMP2 promoterdependent Bax expression'. Together they form a unique fingerprint.

Cite this